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We report the structure of a strictly mitochon-
drial human synthetase, namely tyrosyl-tRNA
synthetase (mt-TyrRS), in complex with an ad-
enylate analog at 2.2 A˚ resolution. The structure
is that of an active enzyme deprived of the C-ter-
minal S4-like domain and resembles eubacterial
TyrRSs with a canonical tyrosine-binding pocket
and adenylate-binding residues typical of class I
synthetases. Two bulges at the enzyme surface,
not seen in eubacterial TyrRSs, correspond to
conserved sequences in mt-TyrRSs. The syn-
thetase electrostatic surface potential differs
from that of other TyrRSs, including the human
cytoplasmic homolog and the mitochondrial
one from Neurospora crassa. The homodimeric
human mt-TyrRS shows an asymmetry propa-
gating from the dimer interface toward the two
catalytic sites and extremities of each subunit.
Mutagenesis of the catalytic domain reveals
functional importance of Ser200 in line with an
involvement of A73 rather than N1-N72 in tyro-
sine identity.
INTRODUCTION
Among aminoacyl-tRNA synthetases, tyrosyl-tRNA syn-
thetases (TyrRSs) present unique features. Although they
belong to class I synthetases with the master signature
sequences ‘‘HIGH’’ and ‘‘KMSKS’’ and a Rossmann-fold
catalytic domain (reviewed in Bedouelle [2005] and Bonne-
fond et al. [2005c]), they are homodimers and recognize
tRNA from the major groove side of the amino acid
acceptor stem, in a way reminiscent to what was found
for class II synthetases (Bedouelle and Winter, 1986; Lee
and RajBhandary, 1991; Yaremchuk et al., 2002). They are
also peculiar with regard to the tRNA identity rules, with the
G1-C72 base pair contributing to tyrosine identity in all
eubacterial tRNATyr (Quinn et al., 1995) and the reverse
C1-G72 pair in archaeal/eukaryal species, where it is the
major tyrosine determinant (Lee and RajBhandary, 1991;
Quinn et al., 1995; Fechter et al., 2000, 2001). This peculiar-Structure 15, 1505–1516ity contrasts with what observed with most identities that
are generally conserved in evolution (Giege´ et al., 1998;
Beuning and Musier-Forsyth, 1999). Further, it explains
why cross-tyrosylations between tRNA and TyrRSs origi-
nating from different kingdoms of life do not occur (Klee-
man et al., 1997; Wakasugi et al., 1998). The structures of
TyrRSs present a conserved gross organization with an
N-terminal catalytic domain followed by the C-terminal
anticodon-binding region. Interestingly TyrRSs show large
variations in sequence and length, due to insertions and
appended domains (Wolf et al., 1999; Bedouelle, 2005).
Additional functions result from these differences, like in-
volvement in splicing for mitochondrial Neurospora crassa
TyrRS (Cherniack et al., 1990) and cytokine activity for a
fragment of human cytoplasmic TyrRS (Wakasugi and
Schimmel, 1999).
The present contribution focuses on human mitochon-
drial TyrRS (mt-TyrRS). Although eubacterial-like in terms
of overall organization, human mt-TyrRS, unexpectedly
charges as well tRNATyr species from eubacteria with a
G1-C72 pair as from eukarya with C1-G72. Thus, tyrosyla-
tion specificity of human mt-TyrRS is unresponsive to the
N1–N72 pair, making this protein, to our knowledge, the
first TyrRS with nonconservation of a universal tyrosine
identity position (Bonnefond et al., 2005b). To gain a
deeper molecular understanding of this surprising prop-
erty, knowledge on the three-dimensional structure is
important. But this knowledge is lacking so far, since no
crystallographic structure of any such human enzyme
(except SerRS from closely related bovine mitochondria
[Chimnaronk et al., 2005] and the human cytosolic/mito-
chondrial GlyRS [Xie et al., 2007]) is presently available.
Also, many human pathologies have been correlated with
defects in mitochondrial tRNAs (Florentz et al., 2003; Tay-
lor and Turnbull, 2005; Brandon et al., 2006) and are ex-
panding toward components of the mitochondrial transla-
tion machinery (Jacobs and Turnbull, 2005; Antonicka
et al., 2006; Scheper et al., 2007), appealing for structural
knowledge on these macromolecules. From another view-
point, the tyrosine system with known TyrRS structures
from all kingdoms of life, represents a robust model to un-
derstand the evolution of aminoacyl-tRNA synthetases.
Here, we present the structure and functional features of
a C-terminally truncated but active version of this human
TyrRS in complex with a tyrosyl-adenylate analog. The, November 2007 ª2007 Elsevier Ltd All rights reserved 1505
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Crystal Structure of Human Mitochondrial TyrRSstructure reveals two characteristic mitochondrial inser-
tions, a peculiar electrostatic potential, and a structural
asymmetry in line with the known functional asymmetry
in the TyrRS family. Further, mutagenesis data confirm
the narrowness of the tRNA acceptor stem entry site and
the functional importance of Ser200 for tRNA recognition.
RESULTS
Solution and Crystallographic Properties
of Human mt-TyrRS
Numerous attempts to crystallize native human mt-TyrRS
led to crystals not suitable for structure resolution (Bonne-
fond et al., 2007). Based on the experience on Staphylo-
coccus aureus, Escherichia coli, and mitochondrial
N. crassa TyrRSs (Qiu et al., 2001; Kobayashi et al., 2005;
Paukstelis et al., 2005), the potentially floppy C-terminal
domain, analogous to ribosomal protein S4 (Figure 1),
was removed. The truncated TyrRS (2 3 356 residues),
called mt-TyrRS-DS4, consists therefore in the N-terminal
catalytic domain followed by the helical a-ACB substruc-
ture of the anticodon-binding region. When purified, this
protein is monodisperse and has a 38 A˚ hydrodynamic
radius (Bonnefond et al., 2007). It is active for tyrosine
activation and charging of native E. coli tRNATyr, although
tyrosylation efficiency kcat/KM is decreased 100-fold
mainly due to a decreased kcat. Notice the inability of
mt-TyrRS-DS4 to charge other native (yeast) or tran-
scribed (E. coli, yeast, human cytosolic and mitochondrial)
tRNATyr species as opposed to the native mt-TyrRS
(Bonnefond et al., 2005b). Interestingly, deletion of the
S4-like domain significantly increases the solubility of the
synthetase, as compared to the full-length protein. This
property is favorable for crystallization, and indeed tetrag-
onal crystals diffracting to 2.7 A˚ resolution could be grown
(Bonnefond et al., 2007). The resolution of the latter could
be extended to 2.2 A˚ when crystallization was conducted
in the presence of the tyrosyl-adenylate analog 50 O-[N-(L-
tyrosyl) sulfamoyl] adenosine (Tyr-AMS). We note that
enzymatic activity and crystallization necessitate reducing
conditions, as was the case for bovine mt-SerRS (Chim-
naronk et al., 2004).
Overall Structure of Human mt-TyrRS-DS4
The structure of human mt-TyrRS-DS4 in complex with
Tyr-AMS was solved by molecular-replacement (MR) with
the E. coli TyrRS (PDB code: 1VBM) (Kobayashi et al.,
2005) as initial search model. The refined model at 2.2 A˚
resolution, yields a crystallographic R factor of 19.6%
with a free R factor of 24.4% (Table 1). It is based on re-
markably good electron density (Figure S1, see the Sup-
plemental Data available with this article online). A second
structure at 2.7 A˚ resolution corresponds to the free
enzyme but gives only a partial view of the molecule. The
C-terminal domain is globally disordered, whereas the
catalytic site is well defined. In what follows, we will con-
centrate on the description of the structure including the
adenylate analog.1506 Structure 15, 1505–1516, November 2007 ª2007 ElsevieThe dimeric structure has an elongated shape with the
C-terminal ends in distal location (110 A˚ in length) (Fig-
ure 2). The structure reveals the modular architecture of
the synthetase with the two N-terminal catalytic domains
in central location of the protein. These catalytic domains
encompass the Rossmann-folds with their typical parallel
b strands (b2 to b6) and the two active sites filled with Tyr-
AMS in extended conformation. The anticodon-binding
modules, constituted by five a helices (a11 to a15), are
located at both distal extremities of the dimer. Finally,
the interface between the two subunits is made by the
CP1 domains (Figure 2). Among the two class I synthetase
signature sequences, only HVGH is seen. This motif is
close to the adenosine moiety of bound Tyr-AMS. The
KLGKS signature sequence is located in the flexible loop
between b6 and a11 connecting the catalytic to the
anticodon binding domains. Notice the location of two
helical structures close to the dimerization interface,
named cluster 1 (a7 and a8) and cluster 2 (a10) (Figures
1B and 2), that were shown to be essential for species-
specific recognition of the amino acid acceptor stem of
tRNATyr (Nair et al., 1997).
In contrast to the crystals of free enzyme that contain
one monomer in the asymmetric unit (Bonnefond et al.,
2007), those of the complex with Tyr-AMS contain the
whole homodimer (Table 1). Remarkably, the two mono-
mers are not identical in the crystals, as revealed by an
overall root-mean-square deviation (rmsd) of 0.5 A˚, which
can reach 3.5 A˚ in several parts of the synthetase subunits
(Figure 3 and Figure S2). Most prominent structural
changes occur in three regions of the subunits. First in
the CP1 region making the interface between the two
subunits (in helix a8 and the following loop connecting to
helix a9), second in the ‘‘ins1’’ region of the catalytic
domain (see below) and third in the a-ACB region that
moves as a rigid body (Figure 3).
Comparison with Other TyrRSs
TyrRS structures originating from 11 organisms, namely
four Archaea (Zhang et al., 2005; Kuratani et al., 2006),
four Eubacteria (Brick et al., 1989; Qiu et al., 2001; Kobaya-
shi et al., 2005; Yaremchuk et al., 2002), an Eukarya (Yang
et al., 2002), a virus (Abergel et al., 2007), and theN. crassa
mitochondria (Paukstelis et al., 2005), have already been
described. Here, we add the structure from human mito-
chondria. Most of these structures, including human
mt-TyrRS, are deprived of the C-terminal domain because
its structural flexibility hampers crystallization. Although
these enzymes present common characteristics, as an
overall similar shape, they show large variations in their
electrostatic surface potentials as depicted in Figure 4
for five representative structures. These variations con-
cern both the TyrRS face recognizing the tRNA and the
opposite face that does not contact tRNA. Below, we
further compare selected structural features of human
mt-TyrRS with those of known TyrRSs including its cyto-
plasmic human homolog.
Sequence alignments show high similarities between
human mt-TyrRS and eubacterial TyrRSs (e.g., 37%,r Ltd All rights reserved
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Crystal Structure of Human Mitochondrial TyrRSFigure 1. Sequence Features of Human Mitochondrial TyrRS
(A) Modular organization of human mt-TyrRS and mt-TyrRS-DS4. The catalytic domain (orange), with the location of the HVGH and KLGKS signature
sequences (blue), is disrupted by the CP1 (connective peptide 1) in black. The anticodon binding region includes the helical a-ACB (anticodon binding)
domain (green) and the S4-like (S4 ribosomal protein-like) domain (yellow) for entire mt-TyrRS. The Nt-located mitochondrial targeting sequence
(MTS) in the native enzyme is shown. Location of cysteine residues is indicated by SH-labeled lines.
(B) Structure-based alignment of human mt-TyrRS sequence (including MTS domain) with TyrRSs from E. coli (PDB code: 1VBM), T. thermophilus
(PDB code: 1H3E), and N. crassa mitochondria (PDB code: 1Y42). Conserved and similar residues are highlighted in red. The secondary structure
elements as found in the crystal structure of mt-TyrRS-DS4 (see Figure 2) are shown above its sequence. Conserved and semiconserved residues
in class I synthetase canonical signature ‘‘HIGH’’ and ‘‘KMSKS’’ sequences are highlighted in blue (blue background and blue scripts, respectively).
Sequences of cluster 1 (residues 194–207) and cluster 2 (residues 248–261) are framed in the alignment. Specific insertions in human (ins1, ins2) and
N. crassa (H0, I, II) mt-TyrRSs are indicated above and under the alignment, respectively. Amino acids interacting with small substrates are pointed in
red (see Figure 6C), and those discussed in the text for tRNA recognition are in green.35%, and 35% identity with native TyrRSs from Bacillus
stearothermophilus, E. coli, and S. aureus, respectively,
despite lower homology in the anticodon-binding domain)
(Bonnefond et al., 2005a). Further, the overall architecture
of mt-TyrRS-DS4 as well is similar to that of known eubac-
terial TyrRSs, with rmsd of 1.30 A˚ for E. coli (PDB code:
1VBM), 1.33 A˚ for B. stearothermophilus (PDB code:Structure 15, 1505–1513TS1), and 1.36 A˚ for S. aureus (PDB code: 1JIL) TyrRSs.
Figure 5A compares human mt-TyrRS-DS4 and E. coli
(PDB code: 1VBM) TyrRS, its closest relative, in complex
with adenylate. Despite the similarities, one notices two
structural idiosyncrasies in the mitochondrial structure.
They are an enlarged loop located between b1 and b2
strands (‘‘ins1,’’ residues 56–70) and a lengthened6, November 2007 ª2007 Elsevier Ltd All rights reserved 1507
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Crystal Structure of Human Mitochondrial TyrRSa4-helix (‘‘ins2,’’ residues 152–166) in the catalytic domain
(Figure 5A). Inspection of mt-TyrRS sequences shows
presence of the ‘‘ins2’’ helix in most organisms, but with
changes in length and sequence, and highlights the verte-
brate character of the ‘‘ins1’’ loop (see Figure S3). Gross
docking of T. thermophilus tRNATyr on human mt-TyrRS
suggests that the ‘‘ins1’’ loop contacts the ribose-phos-
phate backbone of the tRNA acceptor helix and conse-
quently may contribute to the tRNA anchoring onto the
synthetase.
Table 1. Crystal Analysis and Structure Refinement of
Human mt-TyrRS-DS4 in Complex with Two Tyr-AMS
Ligands
Crystal Analysis
Synchrotron beamline ID23-1 (ESRF)
Wavelength (A˚) 0.976
Space group P212121
Unit cell a, b, c parameters (A˚) 54.0, 62.6, 194.6
Crystal mosaicity (deg) 0.64
Resolution range (A˚) 2.2–20 (2.2–2.3)
Number of observations 403043
Number of unique reflections 34168
Completeness (%) 99.5 (100)
Multiplicity 11.8 (12.2)
Rmerge (%) 9.8 (42.7)
I/s(I) 19.1 (8.2)
Solvent content (%) 40, 2.0
Asymmetric unit content two monomers
Structure Refinement
R factor (%) 19.3 (22.8)
Free R factors (%) 24.4 (30.9)
Number of atoms
Protein 5104
Ligand 70
Solvent 90
B factors (A˚2)
Overall 40.4
Protein 40.8
Ligand 32.5
Solvent 39.9
Rmsd for bond
distances (A˚), angles ()
0.008, 1.4
Ramachandran plot (%)a
Most favored region 94.7
Additionally allowed region 4.9
Generously allowed region 0.4
a Statistics from PROCHECK (Laskowski et al., 1996).1508 Structure 15, 1505–1516, November 2007 ª2007 ElsevierTo better understand mitochondrial idiosyncrasies, we
compare the structure of human mt-TyrRS with that from
the yeast N. crassa mitochondria, known to participate in
splicing of mt-group I introns (Akins and Lambowitz,
1987). Overall, the two structures are similar throughout
their whole sequence with an rmsd of 1.75 A˚ (Figure 5B).
Three insertions (H0, I, and II) in the catalytic domain of
the N. crassa enzyme were proposed to be involved in
splicing (Paukstelis et al., 2005). Interestingly, the splicing
platform is opposite to the tRNA recognizing face and has
a positive electrostatic surface potential (Figure 4). Out of
the three insertions, only insertion I is found in human mt-
TyrRS, where it corresponds to ‘‘ins2,’’ with however fewer
residues (Figures 1B and 5B).
Finally it is worth comparing the crystallographic
structure of human mt-TyrRS with that of its cytosolic
counterpart. This enzyme, as well, is merely known under
a minimalist form (Yang et al., 2002), lacking the eukaryal-
specific EMAP-like Ct-terminal domain solved indepen-
dently (Yang et al., 2003). Although both mitochondrial
and cytosolic TyrRSs have the same overall shape, they
strikingly differ in the surface distribution of the electro-
static potential (Figure 4). This might correlate either with
a functioning of the two human enzymes in different phys-
ico-chemical environments or with the binding of alternate
partners in cytoplasm and mitochondria. Note that the
ELR tripeptide responsible for the IL8 cytokine activity of
cytoplasmic mini-TyrRS (Yang et al., 2002) is not present
in the mitochondrial enzyme.
Snapshots in the Active Site
The difference in resolution of free (the original crystal
form) and Tyr-AMS bound mt-TyrRS-DS4 forms (2.7 and
2.2 A˚, respectively) suggests a stabilization of the enzyme
conformation after binding the adenylate analog. The
active site is well defined in the two enzyme forms, with
the exception of the degenerated class I signature KLGKS
that is disordered in both structures, as previously found
in other TyrRSs (e.g., B. stearothermophilus [Brick et al.,
1989] and E. coli [Kobayashi et al., 2005]). This signature
sequence, located at the periphery of the active site where
it plays a functional role in tyrosylation (Xin et al., 2000),
becomes ordered in the TyrRS when in complex with
ATP or tRNATyr (Yaremchuk et al., 2002). In the human
enzyme, Tyr-AMS is clearly defined in the electron density
map (Figure 6A) and accommodates well in the active site
pocket (Figure 6B), where eight amino acids make hydro-
gen bonds with the adenylate analog (Figure 6C). Among
them, two are specific of class I synthetases (Gly244
and Asp246) and warrant discrimination between ATP and
dATP, four are strictly conserved in all TyrRSs (Tyr77,
Tyr221, Gln225, Asp228) and are responsible for tyrosine
recognition, and the two remaining (Asp121, Ile274) are
common to mitochondrial and eubacterial TyrRSs.
Toward a Functional View on tRNATyr Acceptor
End Recognition Site on mt-TyrRS
The active site where catalysis occurs, and defined above
by the binding pocket of adenylate, is completed byLtd All rights reserved
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Crystal Structure of Human Mitochondrial TyrRSFigure 2. Crystallographic Structure of Human mt-TyrRS-DS4
(A) Overall crystallographic structure of dimeric mt-TyrRS-DS4 showing the elongated shape of the protein (color code as in Figure 1A) in its Tyr-AMS-
bound form. One monomer is drawn in ribbon with a transparent surface and clusters 1 and 2 as well as the three cysteine residues emphasized. The
other monomer is drawn as a cartoon with the location of the KLGKS-loop indicated close to the HVGH-motif (in blue) on top of helix a3.
(B) Topology diagram of the dimeric synthetase with the secondary structure elements labeled (a helices shown as circles, and b strands as triangles)
and one monomer (at the right) colored as in Figure 1. The diagram specifies the location of the signature sequences HVGH on a3 and KLGKS in the
loop joining b6 and a11 (in blue on monomer B at the right), as well as of ‘‘ins1’’ between b1 and b2 and ‘‘ins2’’ between a4 and b4 (in red on monomer
A at the left).structural elements that specifically recognize the tyrosine
accepting arm of tRNATyr. These include two helices of
14 amino acids each, the so-called clusters 1 and 2 (Nair
et al., 1997) (Figure 1B) surrounding the catalytic region.
These clusters have the same overall helical geometry
than in other known eubacterial TyrRSs, with a marked
kink in cluster 1, and superimpose best with B. stearother-
mophilus TyrRS without any distortion of their peptide
backbones (rmsd of 0.9 A˚) (Figure 7A). In T. thermophilus
TyrRS, either free or in complex with tRNA (Yaremchuk
et al., 2002), superimposition is worse (rmsd of 2.0 A˚) be-
cause of an intrinsic enlargement of the cleft between theStructure 15, 1505–151two clusters (up to 2.5 A˚) (Figure 7A). The narrowness of
the mt-TyrRS cleft was probed with a mt-tRNATyr variant
presenting an enlarged N1-N72 pair, namely G1-G72.
Aminoacylation assays reveal the inability of the mt-TyrRS
to charge this molecule (Table 2). We have further investi-
gated the enzyme specificity toward the tRNA discrimina-
tor base 73 by testing the three mt-tRNATyr variants U73,
G73, and C73. Whereas variants G73 and C73 are barely
tyrosylated, mutant U73 retains partial aminoacylation
capacity (Table 2).
In the absence of crystallographic data on the human
complex, search for amino acids in contact with the6, November 2007 ª2007 Elsevier Ltd All rights reserved 1509
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Crystal Structure of Human Mitochondrial TyrRStRNA acceptor end is based on sequence comparison of
TyrRSs (Bonnefond et al., 2005b), mutational studies on
the structurally related B. stearothermophilus enzyme
(Labouze and Bedouelle, 1989) and inspection of crystal-
lographic structure of an eubacterial tRNATyrTyrRS com-
plex (Yaremchuk et al., 2002). Potentially essential amino
acids for tRNATyr recognition are thus located in the clus-
ters and in the vicinity of the bacterial tRNA tyrosine iden-
tity determinants A73 and G1-C72 (Figure 7B). We tenta-
tively initiated a mutagenesis analysis by exploring three
potential positions: Ser200 and Gln202 in cluster 1 and
Met252 in cluster 2 (Figure 7A). Residue Ser200 is highly
conserved in mitochondrial TyrRSs and its equivalent in
the B. stearothermophilus enzyme was proposed to rec-
ognize discriminator base A73 (Labouze and Bedouelle,
1989), the strongest tyrosine identity element in human
mt-tRNATyr (Bonnefond et al., 2005c). The second amino
acid, Gln202 may interact with the 30 sequence of tRNATyr
as suggested by docking tRNA on the synthetase. The
third residue, Met252, is strictly conserved in archaeal
TyrRSs and mt-TyrRSs from vertebrate eukaryotes, but
is variable in eubacterial TyrRSs (Bonnefond et al., 2005b).
This Met residue is homologous to residues interacting
with C1 or G1 bases, as seen in two crystal structures
of tRNATyrTyrRS complexes (Yaremchuk et al., 2002;
Kobayashi et al., 2003).
The three amino acids were individually mutagenized in
full-length human mt-TyrRS and activities of the mutant
Figure 3. Conformational Asymmetry in Homodimeric Hu-
man mt-TyrRS-DS4
Superimposition of the two subunits of mt-TyrRS-DS4 in complex with
Tyr-AMS (backbones colored as in Figure 1A, in heavy and light colors
for monomer A and B, respectively). The regions with largest asymme-
tries are circled. Note that the two adenylate analogs (in blue) almost
perfectly superimpose.1510 Structure 15, 1505–1516, November 2007 ª2007 Elsevier Lenzymes tested for amino acid activation and tRNA
aminoacylation. All three enzymes (Ser200Glu, Gln202Ala,
Met252Ala) are fully active in ATP/PPi exchange (not
shown), indicating that the site for tyrosyl-adenylate for-
mation remains unperturbed upon mutation. Tyrosylation
properties determined with human mt-tRNATyr tran-
scripts, either the wild-type molecule or the mutants with
changes at positions 73 or 1–72, are summarized in Table
2. Remarkably, replacing Ser200 with Glu completely
abolishes tyrosylation activity of wild-type and mutated
tRNATyr transcripts. On the contrary, mutating Gln202
and Met252 shows only faint effects on wild-type and mu-
tants mt-tRNATyr charging as compared to what found
with the native enzyme. Surprisingly, tRNA mutant U73
is no more charged by mt-TyrRS upon Met252Ala muta-
tion. Further, the weak tyrosylation activity of tRNATyr
with G73 is completely abolished with both Glu202Ala
and Met252Ala mt-TyrRSs. Notice that tyrosylation inabil-
ity of tRNA with the G1-G72 pair still remains with the three
mt-TyrRS mutants.
DISCUSSION
Structural biology of aminoacyl-tRNA synthetases started
in the 1970s with the crystallographic structure of TyrRS
from B. stearothermophilus (Irwin et al., 1976). Today,
TyrRSs are among the best-known synthetases with a
panel of documented structures, belonging to the three
kingdoms of life, and even from the giant Mimivirus infect-
ing the protist Acanthamoeba polyphaga. However, the
structural knowledge of organellar synthetases remains
limited. The TyrRS investigated in this work led to the first,
to our knowledge, crystal structure of a human aminoacyl-
tRNA synthetase of exclusive mitochondrial location. For
crystallogenesis reasons, this structure corresponds
to a truncated protein lacking the S4-like domain. This
enzyme is active for both tyrosine activation and E. coli
tRNATyr tyrosylation. Likewise, the structure of another
mitochondrial and two eubacterial truncated TyrRSs
could be solved (Qiu et al., 2001; Kobayashi et al., 2005;
Paukstelis et al., 2005). These mini-TyrRSs are active in
tyrosine activation, but in contrast to human mt-TyrRS-
DS4, the truncated E. coli enzyme does not charge tRNA
(Kobayashi et al., 2005). In the case of the S. aureus or
N. crassa mitochondria enzymes, aminoacylation activity
was not tested (Qiu et al., 2001) or was considered a priori
not possible because part of the anticodon binding struc-
ture, namely the S4-like domain, is lacking (Paukstelis
et al., 2005). Note that the S4-like domain interacts also
with the large variable region of eubacterial tRNATyr
(Yaremchuk et al., 2002) that is absent in all mt-tRNATyr
species (Sprinzl and Vassilenko, 2005). Thus, one can
question why evolution has maintained the S4-like mod-
ule in mitochondria. We suggest that the appended S4-
like domain reinforces the interaction between mt-tRNATyr
and the human synthetase. The NMR-structure of the
isolated domain from B. stearothermophilus (Guijarro
et al., 2002), the crystal structure of the T. thermophilus
TyrRS in complex with tRNATyr (Yaremchuk et al., 2002),td All rights reserved
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Crystal Structure of Human Mitochondrial TyrRSFigure 4. Electrostatic Surface Potentials of Several mt-
TyrRS-DS4
Blue, white, and red regions correspond to positive, neutral, and neg-
ative potentials, respectively. Computations used the following coordi-
nates: PDB codes 3TS1, 1WQ3, 2PID (this work), 1Y42, 1N3L. TwoStructure 15, 1505–151and the property of the N-terminal domain of eukaryal
class IIb synthetases, e.g., yeast AspRS, to reinforce tRNA
binding (Frugier et al., 2000), bring support to this view.
The crystals used here could only be grown with synthe-
tase purified under reducing conditions. Likewise, activity
of human mt-TyrRS-DS4 (as well as full-length TyrRS)
requires reducing conditions, indicating the necessity of
nonoxidized cysteine residues for crystallization and func-
tionality. Cysteine residues were proposed to participate
in the catalytic mechanism of yeast TyrRS, based on the
observation that modification of two reactive sulfhydryl
groups per subunit leads to inactivation of the enzyme
(Faulhammer and Cramer, 1977). Given the location of
the cysteine residues in the structure of human mt-TyrRS
(Figure 2), the role of these residues cannot be directly
correlated with the catalytic mechanism of tyrosylation.
Rather, these cysteines affect activity indirectly by pro-
moting formation of an inactive synthetase conformation.
Note that the mitochondrial genetic machinery, including
mt-TyrRS, is located in the matrix, where conditions are
overall reducing (Korge and Weiss, 2006).
Aminoacyl-tRNA synthetases are characterized by an
intrinsic structural plasticity leading to high mobility of cer-
tain structural domains (reviewed in Ibba et al. [2005]). This
propensity of conformational flexibility, often linked to
enzyme function, is well documented in TyrRS structures
(reviewed in Bedouelle [2005]) and finds support with
the properties of human mt-TyrRS. In particular, the
‘‘KMSKS’’ loops are either disordered and not visible in
electron density or present high B factors as compared
to the whole molecule. This is due to high mobility during
each steps of the tyrosylation reaction. In the adenylate-
bound form of human mt-TyrRS-DS4, the ‘‘KMSKS’’
loop is rather remote from the active site, thus explaining
a relative lack of constrains in the structure. Further,
many functional studies concluded for a functional asym-
metry of homodimeric TyrRSs (Bosshard et al., 1975;
Ward and Fersht, 1988) and their half-of-the-sites activity
is well established (Bedouelle, 2005). However, most
TyrRS structures show crystallographic symmetry and
ligand binding to both subunits. This discrepancy was
discussed previously and explained by the duration of
the crystallization assays that allows the TyrRS binding
sites to be filled by their ligands (Yaremchuk et al.,
2002). With the human mt-TyrRS, we clearly observe
a structural asymmetry of the enzyme in complex with
Tyr-AMS. It concerns essentially two regions in the cata-
lytic domain and one region in the anticodon-binding
domain (Figure 4). Although part of this asymmetry could
be due to packing effects, the present structure clearly
shows an intrinsic plasticity of the enzyme in complex
with the adenylate analog. We conjecture that structural
orientations of the TyrRSs (all Ct-truncated) are displayed: the side
where the two tRNA molecules bind to the synthetase (on the left)
and the back orientation rotated by 180 (on the right). The two mito-
chondrial enzymes are framed. Location of the two tRNA molecules
bridging the TyrRS subunits is indicated, as found in the crystal struc-
ture from T. thermophilus (Yaremchuk et al., 2002).6, November 2007 ª2007 Elsevier Ltd All rights reserved 1511
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Crystal Structure of Human Mitochondrial TyrRSFigure 5. Structural Idiosyncrasies in Human mt-TyrRS-DS4
(A) Comparison of the TyrRS-DS4 subunits of human mitochondria (monomer B, this work) and E. coli (PDB code: 1VBM). Backbone of mt-TyrRS is
colored as in Figure 1A and that of E. coli TyrRS in light blue.
(B) Comparison of the mt-TyrRS-DS4 subunits of human (monomer B, this work) andN. crassa (PDB code: 1Y42). Human mt-TyrRS is colored as in (A)
and that from N. crassa in yellow. To emphasize the structural differences, the superimpositions are displayed under two orientations. Notice that
N. crassa-specific elements II and H0 (colored in yellow) are absent in the human protein.perturbations propagate from the dimer interface toward
the two catalytic sites and the a-ACB modules at the
protein distal extremities. A similar behavior was recently
reported for the 322 residue long C-truncated E. coli
TyrRS but restricted to the sole structural asymmetry in
the ‘‘KMSKS’’ loops (Kobayashi et al., 2005).1512 Structure 15, 1505–1516, November 2007 ª2007 ElseviSo far, no suitable crystals of the mt-TyrRStRNA com-
plex could be grown (Bonnefond et al., 2007) and only par-
tial answers can be given on the tRNA binding over the two
subunits (Figure 4). Docking of tRNA (in the conformation
seen in T. thermophilus complex [Yaremchuk et al., 2002])
on the human enzyme necessitates structural distortionsFigure 6. Snapshot in the Active Site of Dimeric Human mt-TyrRS-DS4
(A) Electron density of the two Tyr-AMS adenylate analogs in complex with mt-TyrRS-DS4 (from monomer A on the left and monomer B on the right).
(B) Active site pocket with the bound Tyr-AMS and the HVGH domain on top of helix-a3 emphasized in blue. Notice, the proximity of the adenine ring
from Tyr-AMS with the imidazole ring from His88 and His91, the two residue from the HVGH signature sequence.
(C) Cartoon of the well resolved adenylate analog (in blue) and the network of nine H-bond contacts it makes with the eight essential amino acids from
the catalytic site. Amino acids specific to class I synthetases are boxed; those strictly conserved in TyrRSs are labeled in bold, and those specific to
mitochondrial and eubacterial TyrRSs in red.er Ltd All rights reserved
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the tRNA to contact simultaneously the catalytic and anti-
codon binding domains. This is in line with the structural
plasticity of mammalian mt-tRNAs allowing the two
branches of the L to vary their angle (Helm et al., 2000).
Despite important sequence variability in the a-ACB do-
main, we notice the presence in the human enzyme of res-
idue Asp311, homologous to Asp259 in T. thermophilus
TyrRS that interacts with the anticodon base G34 of cog-
nate tRNATyr (Yaremchuk et al., 2002). Other amino acids
identified as anticodon binders are not conserved in
human mt-TyrRS.
As to the binding site of the acceptor arm, human mt-
TyrRS is functionally characterized by its lack of specificity
toward a canonical N1-N72 pair in tRNATyr. This is in
contrast to eubacterial, archaeal, and eukaryal TyrRSs
that recognize respectively G1-C72 and C1-G72 pairs,
implying that N1-N72 does not belong to the tyrosine iden-
tity set in human mitochondria. Interestingly, disrupting
N1-N72 pair in mt-tRNATyr by replacing C at position 72
by a G completely abolishes the charging ability of the
tRNA. This suggests that the mutated tRNA with an en-
larged and distended geometry of the acceptor helix, due
to the G1-G72 pair, cannot adapt the acceptor end in the
narrow active site cleft formed by the cluster sequences.
Altogether, disregarding the nature of the N1-N72 base
pair, its surface and geometry is critical for allowing or
preventing tRNATyr recognition.
Previous sequence and structure analysis of TyrRSs
revealed a mosaic nature of the two clusters whose amino
acids are in vicinity or in contact with the tRNATyr acceptor
Figure 7. Role of Clusters 1 and 2 in tRNATyr Acceptor Arm
Recognition
(A) Superimposition of the cleft formed by the two helical structures of
clusters 1 and 2 (in which binds the tyrosine acceptor arm of tRNATyr) in
the crystallographic structures of human mt-TyrRS (in brown),B. stear-
othermophilus TyrRS (in blue), and T. thermophilus TyrRS in complex
with tRNATyr (in green). Notice the quasiperfect superimposition of
the two clusters in human mt-TyrRS and B. stearothermophilus TyrRS
and the important structural deviations in T. thermophilus TyrRS. The
bar at the bottom of the figure shows the position where the cleft is
largest (d = 9.9, 10.0, and 12.4 A˚ in the TyrRSs from human mitochon-
dria, B. stearothermophilus, and T. thermophilus, respectively, indicat-
ing an enlargement of the cleft in T. thermophilus of 2.5 A˚). The three
amino acids that were mutagenized are indicated.
(B) View of the clusters and their proximity with the tRNA acceptor
branch as seen in the crystal structure of the T. thermophilus complex
(Yaremchuk et al., 2002).Structure 15, 1505–1516end (Bonnefond et al., 2005b). To shed light toward under-
standing tRNATyr binding on the catalytic domain, we ini-
tiated a mutagenesis analysis conducted with both TyrRS
and tRNATyr variants. Our analysis is completed by former
studies on the phylogenetically related B. stearothermo-
philus TyrRS (Labouze and Bedouelle, 1989). Notably,
both studies pinpoint the functional importance of an
amino acid from the binding site, namely Ser200 in the
human enzyme and its homolog Ala150 in the Bacillus
TyrRS. Importance of this Ser residue is strengthened by
the inability of tRNATyr variants to compensate the nega-
tive effect of the enzyme mutation. On the other hand,
we recall that the discriminator base 73 was shown to
determine conformation of the tRNA 30 end (Limmer et al.,
1993; Puglisi et al., 1994). In this view, one can understand
the decreased ability of N73 variants to be tyrosylated
by both native and Gln202Ala TyrRSs. Notice that U73
partially mimics the structural effect triggered by A73 in
contrast to C73 and G73. This is however not the case
for Met252Ala mt-TyrRS that cannot accommodate U73
tRNATyr in the absence of the Met side chain.
Altogether, the present knowledge on the three-dimen-
sional structure and functionality of human mt-TyrRS are
in light with the sequence-based phylogeny of TyrRSs
(Bonnefond et al., 2005c) and the evolutionary relationship
between mitochondria and eubacteria. More precisely,
the relaxed tyrosine identity in human mitochondria, a
property likely idiosyncratic to vertebrate mt-TyrRSs,
would be achieved by a decreased number of specific
contacts between tRNA and synthetase and not by the
presence of archaeal features (i.e., Met252) as suggested
by sequence comparisons (Bonnefond et al., 2005b).
Additional mutagenesis and crystallographic studies on
the complex with tRNATyr are required to fully understand
these functional peculiarities. Interestingly, altered identity
elements were already described in other mitochondrial
systems (Lovato et al., 2001; Chimnaronk et al., 2005). It
remains to be investigated whether the strategy of reduc-
ing the number of identity elements is employed by other
mitochondrial synthetases. Structure-function studies on
human mt-AspRS support this prediction (Fender et al.,
2006).
EXPERIMENTAL PROCEDURES
Preparation of mt-TyrRSs and mt-tRNATyr Transcripts
Top10 E. coli strains containing plasmids of full-length or truncated
TyrRS were grown in LB medium and TyrRS expression induced
with IPTG. Recovered cells, suspended in a phosphate buffer at pH
8.0, were sonicated and resulting supernatant resolved with an imidaz-
ole gradient on a Ni-NTA column (QIAGEN). Enzyme fractions were
dialyzed against HEPES-NaOH (pH 6.7), NaCl 300 mM, DTE 10 mM,
and 50% glycerol. Glycerol was removed from the concentrated pro-
tein solution by two successive dialyses against the same buffer but
with 10% glycerol and finally without glycerol. Experimental details
and exact sequence at both extremities of the cloned enzyme were
described previously (Bonnefond et al., 2005a, 2007).
The three variants of full-length human mt-TyrRS (Ser200Glu,
Gln202Ala, and Met252Ala) were prepared with the QuickChange
site-directed mutagenesis kit (Stratagene). Protein expression and, November 2007 ª2007 Elsevier Ltd All rights reserved 1513
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Crystal Structure of Human Mitochondrial TyrRSTable 2. Kinetic Parameters of the Tyrosylation Reaction of Various Human Mitochondrial tRNATyr Transcripts by
Native and Mutated Human mt-TyrRS
mt-TyrRS mt-tRNATyr KM (mM) kcat (10
3$s1) kcat/KM (10
3$s1$mM1) L (x-fold)
native WT (A73; G1-C72) 1.5 46 31 1
U73 1.3 0.8 0.6 52
G73 24 0.05 0.002 15 500
C73 nm nm nm nm
G1-G72 nm nm nm nm
Ser200Glu WT nm nm nm nm
U73 nm nm nm nm
G73 nm nm nm nm
C73 nm nm nm nm
G1-G72 nm nm nm nm
Gln202Ala WT 2.7 140 52 0.6
U73 2.1 1.3 0.6 52
G73 nm nm nm nm
C73 nm nm nm nm
G1-G72 nm nm nm nm
Met252Ala WT 1.7 45 26 1.2
U73 nm nm nm nm
G73 nm nm nm nm
C73 nm nm nm nm
G1-G72 nm nm nm nm
All proteins are fully active in ATP/PPi exchange assay; nm, not measurable; L, loss in tyrosylation efficiency as compared to the
wild-type system (expressed as kcat/KM ratios).purification were conducted under reducing conditions as indicated
above.
Wild-type human mt-tRNATyr transcript was prepared according to
established procedures as described in Bonnefond et al. (2005a). Var-
iants of tRNATyr presenting mutations at positions 73 and 1–72 were
synthesized and purified following the same protocols.
Functional Assays
ATP/PPi exchange was done in media containing 100 mM HEPES-
NaOH (pH 7.2), 10 mM MgCl2, 2 mM KF, 2 mM ATP, and 2 mM
[32P]PPi (1–2 cpm/pmol). Reactions were initiated by adding 1 mg of
the appropriate mt-TyrRS version. The [32P]ATP formed after incuba-
tion at 37C was determined as described (Campanacci et al., 2004).
Controls with no TyrRS or no amino acid were conducted in parallel.
Aminoacylation of native mt-tRNATyr or mt-tRNATyr transcripts was
performed as described (Bonnefond et al., 2005b). Kinetic parameters
KM and kcat were determined from Lineweaver-Burk plots. Displayed
data are averages of at least two independent experiments.
Crystallization and Structure Determination
Initial tetragonal crystals were obtained by vapor-diffusion (sitting
drops of 600 nl to 2 ml) in CrystalQuick microplates (Greiner Bio-One)
prefilled with EasyXtal screens (QIAGEN) (Bonnefond et al., 2007).
Starting from these conditions 30% PEG 4000 w/v, 200 mM NH4
acetate, 100 mM Na acetate (pH 4.6), an orthorhombic crystal form
with a prismatic habit was obtained in the presence of 5 mM Tyr-
AMS (RNA-tec, Belgium) and rising the pH from 4.6 to 6.5 by addition
of 100 mM Tris-HCl (pH 7.5) (from Optisalt additive screen, QIAGEN).1514 Structure 15, 1505–1516, November 2007 ª2007 ElsevieThese crystals of 200 mm in their largest dimension diffract X-rays to
2.2 A˚ resolution.
Crystals were mounted in cryoloops (Hampton Research) and flash
frozen in a nitrogen stream after brief soaking in cryoprotecting Para-
tone (Hampton Research). They were analyzed at 100K on beamline
ID23-1 (ESRF, France) equipped with an ADSC Quantum 315 CCD
detector. Data were processed with the XDS package (Kabsch,
1993). Analysis of solvent content performed with the CCP4 package
(CCP4, 1994) gave a unique solution consisting of one or two polypep-
tide chain(s) per asymmetric unit in the case of native (tetragonal) or
Tyr-AMS substituted (orthorhombic) crystals, respectively. A molecu-
lar-replacement (MR) solution was found for the original tetragonal
crystals (space group P43212) by using the structure of the closely re-
lated E. coli ortholog (Bonnefond et al., 2007), but the last 80 C-termi-
nal residues (corresponding to the a-ACB module) could not be built
due to the lack of interpretable electron density. Finally, the MR solu-
tion after partial refinement was used as a starting point for MR by us-
ing orthorhombic data. In contrast to the tetragonal situation, a near to
complete chain could be traced for the two monomers of mt-TyrRS-
DS4 in the orthorhombic unit cell at a resolution of 2.2 A˚. Model build-
ing and refinement were carried out using Coot (Emsley and Cowtan,
2004) and CNS (Bru¨nger et al., 1998), respectively. The final structure
includes 317+324 out of 2 3 356 residues (lacking regions 28–36, 66–
72, 276–288, and 374–383 [including the 6-His tag] in monomer A and
28–36, 276–288, and 374–383 [with the 6-His tag] in monomer B), two
adenylate analogs, and 90 water molecules. Data collection and refine-
ment statistics are given in Table 1. Rmsd were calculated with PyMol
and LSQMAN (DeLano, 2002; Kleywegt and Jones, 1994). Electro-
static potential surfaces were represented with the APBS moduler Ltd All rights reserved
Structure
Crystal Structure of Human Mitochondrial TyrRS(Baker et al., 2001) of PyMol. Docking of tRNA on TyrRS was achieved
by using the SSM algorithm (Krissinel and Henrick, 2004) and the tRNA
structure as seen in the complex with T. thermophilus TyrRS (Yarem-
chuk et al., 2002).
Supplemental Data
Supplemental Data include three figures (one of sequence alignment of
mitochondrial TyrRSs) and are available online at http://www.
structure.org/cgi/content/full/15/11/1505/DC1/.
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